Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Favipiravir”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04918927
What this trial is testing

Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19

Who this might be right for
Covid19
Coordinación de Investigación en Salud, Mexico 120
Large-scale testing (Phase 3)Study completedNCT04818320
What this trial is testing

Favipiravir in High-risk COVID-19 Patients

Who this might be right for
Covid19
Penang Hospital, Malaysia 500
Large-scale testing (Phase 3)Study completedNCT04303299
What this trial is testing

Fight COVID-19 Trial

Who this might be right for
SARS-COV-2 InfectionsCOVID-19
Department of Medical Services Ministry of Public Health of Thailand 320
Early research (Phase 1)Study completedNCT04478448
What this trial is testing

Bioequivalence Study of Favipiravir From Flupirava 200 mg Tablet (European Egyptian Pharmaceutical Industries , Egypt) Versus Avigan 200 mg Tablets (Man. by Toyama Chemical Co., Ltd Japan)

Who this might be right for
Healthy
Genuine Research Center, Egypt 26
Large-scale testing (Phase 3)UnknownNCT04558463
What this trial is testing

The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19

Who this might be right for
Covid19
Universitas Indonesia 100
Large-scale testing (Phase 3)Study completedNCT02008344
What this trial is testing

Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults

Who this might be right for
Influenza
MDVI, LLC 1,161
Large-scale testing (Phase 3)UnknownNCT04694612
What this trial is testing

Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal

Who this might be right for
Covid19
Nepal Health Research Council 676
Testing effectiveness (Phase 2)Study completedNCT04532931
What this trial is testing

Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19

Who this might be right for
COVID-19
Shin Poong Pharmaceutical Co. Ltd. 192
Testing effectiveness (Phase 2)Study completedNCT04499677
What this trial is testing

FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals

Who this might be right for
COVID-19
University College, London 240
Large-scale testing (Phase 3)Study completedNCT04600895
What this trial is testing

The Prevent Severe COVID-19 (PRESECO) Study

Who this might be right for
Covid19
Appili Therapeutics Inc. 1,187
Post-approval studies (Phase 4)UnknownNCT04359615
What this trial is testing

Favipiravir in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT04346628
What this trial is testing

Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19

Who this might be right for
Sars-CoV2COVID-19
Stanford University 149
Not applicableUnknownNCT04310228
What this trial is testing

Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019

Who this might be right for
COVID-19
Peking University First Hospital 150
Early research (Phase 1)UnknownNCT04651959
What this trial is testing

Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions

Who this might be right for
Bioequivalence
Pharma Plant 30
Large-scale testing (Phase 3)Study completedNCT04613271
What this trial is testing

Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia

Who this might be right for
Infectious DiseaseSARS-CoV InfectionCovid19
Ina-Respond 130
Early research (Phase 1)Study completedNCT01419457
What this trial is testing

Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment

Who this might be right for
HealthyHepatic Impairment
MDVI, LLC 36
Not applicableStudy completedNCT04392973
What this trial is testing

FAvipiravir and HydroxyChloroquine Combination Therapy

Who this might be right for
COVID19
King Abdullah International Medical Research Center 268
Large-scale testing (Phase 3)UnknownNCT04828564
What this trial is testing

Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19

Who this might be right for
SARS-CoV2COVID-19
The Scientific and Technological Research Council of Turkey 100
Not applicableUnknownNCT04333589
What this trial is testing

Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive

Who this might be right for
COVID-19
Peking University First Hospital 210
Large-scale testing (Phase 3)Ended earlyNCT04529499
What this trial is testing

Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients

Who this might be right for
Covid19
Dr. Reddy's Laboratories Limited 353
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation